Principia Biopharma Inc (PRNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRNB | KNSA | DNLI | ||
| Company | Principia Biopharma Inc | Kiniksa Pharmaceuticals International Plc | Denali Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.99 | 45.40 | 21.13 | ||
| High | 100.37 | 45.91 | 21.37 | ||
| Low | 99.95 | 44.74 | 20.54 | ||
| Latest | 100.05 | 44.90 | 20.57 | ||
| Change | +0.10 | -0.42 | -0.14 | ||
| % Change | +0.10% | -0.93% | -0.68% | ||
| Volume | 1,792,700 | 1,013,400 | 1,462,000 | ||
| 20-Day Average Volume | 874,435 | 601,435 | 2,001,090 | ||
| Previous Close | 99.95 | 45.32 | 20.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 100.04 | 46.82 | 19.98 | ||
| 20-Day Raw Stochastic | 27.62% | 8.88% | 48.39% | ||
| 20-Day Relative Strength | 65.96 | 45.54 | 52.07 | ||
| Weighted Alpha | +128.20 | +78.08 | +37.29 | ||
| Today's Opinion | 100% Buy | 56% Buy | 80% Buy | ||
| Previous Opinion | 88% Buy | 64% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 09/18/20 | -4.63% since 04/10/26 | +6.97% since 04/10/26 | ||
| Low | 99.90 on 09/24/20 | 44.74 on 04/17/26 | 19.02 on 04/13/26 | ||
| High | 100.37 on 09/25/20 | 48.46 on 04/13/26 | 21.80 on 04/16/26 | ||
| 1-Month | |||||
| %Chg | -1.01% since 08/25/20 | -4.51% since 03/17/26 | -0.68% since 03/17/26 | ||
| Low | 99.76 on 09/04/20 | 44.36 on 03/19/26 | 17.86 on 03/30/26 | ||
| High | 101.25 on 08/26/20 | 50.03 on 04/06/26 | 23.46 on 03/25/26 | ||
| 3-Month | |||||
| %Chg | +68.24% since 06/25/20 | +13.93% since 01/16/26 | +14.34% since 01/16/26 | ||
| Low | 53.36 on 07/09/20 | 38.40 on 01/20/26 | 17.18 on 01/20/26 | ||
| High | 101.89 on 08/25/20 | 50.03 on 04/06/26 | 23.77 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | +82.84% since 03/25/20 | +16.20% since 10/17/25 | +23.47% since 10/17/25 | ||
| Low | 47.22 on 04/03/20 | 35.20 on 10/28/25 | 13.75 on 11/07/25 | ||
| High | 101.89 on 08/25/20 | 50.03 on 04/06/26 | 23.77 on 02/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,322,560 | 3,436,422 | 3,262,217 | ||
| Shares Outstanding, K | 33,209 | 76,535 | 158,591 | ||
| Annual Sales | 35,160,000 | 677,560,000 | 0 | ||
| Annual Net Income | -53,790,000 | 59,010,000 | -512,540,000 | ||
| Last Quarter Sales | 50,000,000 | 202,130,000 | 0 | ||
| Last Quarter Net Income | 10,810,000 | 14,200,000 | -128,550,000 | ||
| 60-Month Beta | 0.86 | 0.06 | 1.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.17 on 02/24/26 | -0.73 on 02/26/26 | ||
| Latest Earnings Date | 11/03/20 | 05/05/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 61.24 | 0.00 | ||